ELIQUIS – apixaban 0.5 mg tablet for oral suspension

ELIQUIS – apixaban 1.5 mg (0.5 mg x 3) tablet for oral suspension

ELIQUIS – apixaban 2 mg (0.5 mg x 4) tablet for oral suspension

Bristol Myers Squibb

deep venous thrombosis; thrombosis with thrombocytopenia syndrome; knee replacement deep vein thrombosis prevention; prevent thromboembolism in chronic atrial fibrillation; hip surgery deep vein thrombosis prevention; pulmonary thromboembolism; thrombosis in heparin-induced thrombocytopenia; prevention of venous thromboembolism recurrence

deep venous thrombosis; prevention of venous thromboembolism recurrence; thrombosis in heparin-induced thrombocytopenia; knee replacement deep vein thrombosis prevention; thrombosis with thrombocytopenia syndrome; pulmonary thromboembolism; prevent thromboembolism in chronic atrial fibrillation; hip surgery deep vein thrombosis prevention

thrombosis with thrombocytopenia syndrome; deep venous thrombosis; hip surgery deep vein thrombosis prevention; prevent thromboembolism in chronic atrial fibrillation; pulmonary thromboembolism; knee replacement deep vein thrombosis prevention; thrombosis in heparin-induced thrombocytopenia; prevention of venous thromboembolism recurrence

Controlled Room Temp (20-25°C)